about
Herbal medicines for fatty liver diseasesProbiotics for patients with hepatic encephalopathyHerbal medicines for fatty liver diseasesMechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammationEssential phospholipids in fatty liver: a scientific updateMedical nutrition therapy in non-alcoholic fatty liver disease--a review of literatureLifestyle interventions for the treatment of non-alcoholic fatty liver diseaseUridine prevents fenofibrate-induced fatty liverLiver Patt1 deficiency protects male mice from age-associated but not high-fat diet-induced hepatic steatosisHepatic fat during fasting and refeeding by MRI fat quantification.Dietary recommendations for patients with nonalcoholic fatty liver diseaseEffects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease.Autophagy protects against palmitate-induced apoptosis in hepatocytesFXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats.Enhanced amelioration of high-fat diet-induced fatty liver by docosahexaenoic acid and lysine supplementationsInhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilizationEvaluation of fatty liver fibrosis in rabbits using real-time shear wave elastographyThe medical risks of obesity.Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL/6J miceSurgical treatment of nonalcoholic fatty liver disease in severely obese patientsAssociation between non-alcoholic fatty liver disease and ischemic strokeBerberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.Protective effect of whey proteins against nonalcoholic fatty liver in rats.Does diagnosing fatty liver and chronic kidney disease do more good than harm?Raspberry ketone protects rats fed high-fat diets against nonalcoholic steatohepatitis.Bai-Hu-Jia-Ren-Shen-Tang Decoction Reduces Fatty Liver by Activating AMP-Activated Protein Kinase In Vitro and In Vivo.Quantitative trait loci affecting liver fat content in mice.Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers.Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of nonalcoholic fatty liver disease.Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?Effective treatment of steatosis and steatohepatitis by fibroblast growth factor 1 in mouse models of nonalcoholic fatty liver diseaseThe Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical TrialPharmacological treatment of non-alcoholic steatohepatitis: the current evidence.Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats.How should we manage patients with non-alcoholic fatty liver disease in 2007?Treating nonalcoholic fatty liver disease.Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease.Non-alcoholic fatty liver disease and the metabolic syndrome: an update.Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury.Obesity: a review of pathogenesis and management strategies.
P2860
Q24200256-4E132675-A83C-4F31-B0FA-CEADC935A69AQ24235259-34128688-A874-4910-8B02-576BFEF071A2Q24236298-BC413D59-DB3C-4D54-A23A-8B22F2AEA07EQ26745839-5FD01821-506E-4C58-A891-8A042DC90930Q26746216-0C7D1196-2BB5-4B9A-A811-1F716018BE4EQ26782452-DBEAADFA-43D6-455A-BE57-0A0264FE02D1Q26862945-D4C065D7-1CD6-422C-B6E2-373CE153C287Q27325516-0CEA6D97-5923-4DA0-BB27-200E48560174Q28586093-D691584D-865F-44C2-B8FE-5B9B15A29CF7Q30769371-D49F32AA-DB3E-4331-AB01-D620EAABC00BQ33636695-F7689A95-6134-4667-9B91-BF41A2E19D2EQ33667280-90B0CA1E-3BFA-41C8-A9AB-C87B007CC52CQ33712340-4BA45F1B-21F8-4B7B-99F1-65492CCA416FQ33741191-832BB34A-1BC3-4E3A-AFFA-9CBCCB373D68Q33748530-1C39016E-8817-4833-9D4D-68E62B74F101Q33824907-A39E847A-8DFE-4C0F-9712-13C992359E0FQ33837347-E3849D8B-1E00-467D-A2EF-A6BD8B44D0D0Q33888248-A17A53B9-B38B-439A-89C1-89D77CF07FDFQ34170885-3AC9A0E4-423C-4735-9BE1-E81285ED5180Q34446294-0E99665F-E10C-4EFE-9828-AB1130D81F8DQ34558966-B171A3B7-CFDD-479B-AFA2-E5776EA15C97Q34603754-319A28C0-E4C3-4428-BED3-4A0342F92234Q34987437-C13D8A11-B647-417C-B535-C2FE87D13912Q35210916-C6E38985-951D-4559-AAD0-1AD81B27F996Q35916987-7F5B25BB-07F0-4866-B2D2-DA1829073591Q36174315-6F6D1253-0DD7-4708-99B0-1E2F460802C6Q36196049-AEDE6602-AB6C-4223-B7E7-950CF41325CBQ36249192-A41450F1-8D2C-47BD-AC85-8D9632400F5EQ36502250-49D6AEEB-1996-49E4-96CE-4473F615F1F5Q36602895-65C8CA4B-5E3E-43C9-B82D-CA4BA3117691Q36646646-6E2CECA4-AC43-4A7D-86FA-230193416D73Q36732958-D77A50E3-1175-40AF-AC39-6C668FD9B2AFQ36747250-A97601C9-9D81-4AC6-9520-226F1C1C7BF7Q36754833-6AFC430F-2E5A-4EEF-9FB0-293AE25E9810Q36848280-83A097BE-8CEF-4ECD-8F67-1CFBD4158C2AQ36962239-650A86BD-ADC4-4E2E-A21E-84E88287C6AEQ36986160-7E83DCBB-897B-4EF3-8CB7-A7CCF8913514Q37054351-9C6FA330-7F28-4A41-84E1-0C5B29B17116Q37061460-B8CB1393-17F1-4C90-8890-6FC5091A0A4DQ37061997-250377E8-EC2D-4ADF-8B7E-DA4E030BA791
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Treatment of non-alcoholic fatty liver disease
@ast
Treatment of non-alcoholic fatty liver disease
@en
Treatment of non-alcoholic fatty liver disease
@nl
type
label
Treatment of non-alcoholic fatty liver disease
@ast
Treatment of non-alcoholic fatty liver disease
@en
Treatment of non-alcoholic fatty liver disease
@nl
prefLabel
Treatment of non-alcoholic fatty liver disease
@ast
Treatment of non-alcoholic fatty liver disease
@en
Treatment of non-alcoholic fatty liver disease
@nl
P2860
P3181
P356
P1476
Treatment of non-alcoholic fatty liver disease
@en
P2093
P2860
P304
P3181
P356
10.1136/PGMJ.2005.042200
P407
P577
2006-05-01T00:00:00Z